期刊文献+

拉莫三嗪与丙戊酸钠先后致皮疹、红细胞巨幼化及高敏综合征 被引量:8

Rash,megaloblastic and hypersensitivity syndrome caused by the use of lamotrigine and valproate
下载PDF
导出
摘要 1例64岁男性患者,因癫痫反复发作口服丙戊酸钠(500 mg,bid)及拉莫三嗪(25 mg,qd)进行治疗,30 d后因发热、皮疹、抽搐、行走障碍入院。骨穿刺结果提示红细胞形态呈巨幼化,予氯雷他定(10 mg,qd,po)及复方甘草酸苷(60 mg,qd,ivgtt),停用拉莫三嗪,改用口服丙戊酸钠(早上750 mg,下午500 mg)抗癫痫,12 d后患者病情好转出院,继续服用丙戊酸钠抗癫痫。2 d后患者皮疹及发热再次加重入院,予甲泼尼龙(40 mg,bid,ivgtt)、氯雷他定(10 mg,qd,po)及复方甘草酸苷(60 mg,qd,ivgtt),停用丙戊酸钠改用苯巴比妥钠(100 mg,bid,im)抗癫痫治疗,20 d后改为苯巴比妥钠(30 mg,bid,po),期间患者发热及皮疹消退、肝功能恢复,于第22天出院。 A 64-year-old male patient was given valproate (500 mg, bid) and lamotrigine (25 mg, qd) for 30 days becauseof epileptic recurrent seizures. The patient was admitted to hospital for fever, rash, convulsions, walking disorders. Bone biopsytest indicated megaloblastic erythrocytes. Loratadine (10 mg, qd, po), compound glycyrrhizin (60 mg, qd, ivgtt) were given andlamotrigine was stopped immediately. Valproate was administrated orally 750 mg in the morning and 500 mg in the afternoon to treatepilepsy. The condition of the patient improved after 12 days, and the patient took valproate when he was discharged from hospital.Two days later, the patient was admitted to hospital because of the aggravated rash and fever. Methylprednisolone (40 mg, bid, ivgtt),loratadine (10 mg, qd, po) and compound glycyrrhizin (60 mg, qd, ivgtt) were given immediately, the valproate was stopped, and thephenobarbital (100 mg, bid, im) was given to treat epilepsy. After 20 days, phenobarbital injection was adjusted with oral dosage form(30 mg,bid,po). The fever and rash disappeared, while the liver function of the patient recovered, finally the patient discharged onthe 22nd day.[KEY WORDS]
出处 《中国药物应用与监测》 CAS 2014年第2期125-127,共3页 Chinese Journal of Drug Application and Monitoring
关键词 拉莫三嗪 丙戊酸钠 癫痫 皮疹 高敏综合征 Lamotrigine Valproate Epilepsy Rash Hypersensitivity syndrome
  • 相关文献

参考文献8

二级参考文献47

共引文献31

同被引文献70

  • 1陆川,张梦琪,茅晓寅,贾晶莹,刘罡一,余琛.LC-MS/MS法同时测定人血清中卡马西平和拉莫三嗪浓度[J].中国药房,2011,22(6):514-516. 被引量:8
  • 2袁洪波,朱毅,陈力.拉莫三嗪片不良反应回顾性分析[J].现代预防医学,2012,39(22):6088-6090. 被引量:10
  • 3郑广群.抗癫癎药高敏反应综合征二例[J].临床误诊误治,2005,18(11):843-843. 被引量:1
  • 4De Hert M,Dobbelaere M,Sherida EM,et al.Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents:a systematic review of randomized,placebo controlled trials and guidelines for clinical practice[J].Euro Psychiatry,2011,26(3):144.
  • 5Joyce NH,Fallon CK,Deborah MA,et al.Antipsychotic medication prescriibing trends in children and adolescents[J].J Pediatric Health Care,2012,26(2):139.
  • 6David F,Christoph UC,Jessica MN,et al.Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders:comprehensive review of prospective head-to-head and placebo-controlled comparisons[J].ENP,2011,21(8):621.
  • 7Leila BA.Antipsychotics in pediatric and adolescent patients:a review of comparative safety data[J].J Affect Disorders,2012,138:S22.
  • 8Masi G,Liboni F.Management of schizophrenia in children and adolescents[J].Focus on Pharmacother Drugs,2011,71(2):179.
  • 9Haas M,Eerdekens M,Kushner L,et al.Efficacy,safety and tolerability of two dosing regimens in adolescent schizophrenia:a double-blind study[J].The British J Psychiatry,2009,194(2):158.
  • 10Haas M,Unis AS,Armenteros J,et al.A 6-week,randomized,double blind placebo-controlled study of the efficacy and safety of risperidone in adolescent with schizophrenia[J].J Child and Adolescent Psychopharmacology,2009,19(6):611.

引证文献8

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部